Australia connects metabolic hormone leptin with vaccine response

Reduced levels of a metabolic hormone known as leptin, largely produced by fat tissue, is linked to poor vaccine antibod...

May 28, 2021 | Friday | News
CEPI injects additional funding of $173.4 M into Korean firm SK bioscience's vaccine project

CEPI, the Coalition for Epidemic Preparedness Innovations, and SK bioscience have announced an expanded partnership to d...

May 28, 2021 | Friday | News
Singapore approves new storage condition for Pfizer COVID-19 vaccine

The Health Sciences Authority (HSA) in Singapore has approved the new storage condition for the Pfizer-BioNTech COVID-19...

May 26, 2021 | Wednesday | News
CanSino receives GMP certificate for Convidecia™, COVID-19 vaccine

CanSino Biologics Inc has announced that its recombinant novel coronavirus vaccine, (Adenovirus Type 5 Vector) (‘A...

May 25, 2021 | Tuesday | News
South Korea explores expansion of COVID-19 vaccine activities

Novavax, Inc., a US-based biotechnology company developing next-generation vaccines for serious infectious diseases, has...

May 25, 2021 | Tuesday | News
RDIF, Panacea Biotec launch production of Sputnik V in India

The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) and Panacea Biotec, one of the leading v...

May 24, 2021 | Monday | News
Research confirms trusted sources key to vaccination program success

Last month was World Immunization Week and never has it been a more pertinent milestone. It has been 13 months since the...

May 24, 2021 | Monday | Opinion
Singapore extends use of Pfizer-BioNTech COVID-19 vaccine to adolescents

The Health Sciences Authority (HSA) at Singapore has extended the authorisation of Pfizer-BioNTech COVID-19 vaccine for ...

May 19, 2021 | Wednesday | News
Australia to soon roll-out single-dose COVID-19 vaccine

A single-dose vaccine that targets new COVID-19 variants has been awarded funding to fast-track testing in human trials....

May 17, 2021 | Monday | News
Moderna to supply 25 M vaccine doses to Australia

Moderna, Inc., has announced a new supply agreement with the government of Australia for 25 million doses. Thi...

May 14, 2021 | Friday | News
Fosun, BioNTech invest $200 M to manufacture COVID-19 vaccine in China

Shanghai Fosun Pharma has signed a Joint Venture with BioNTech to manufacture mRNA vaccine in China. The JV will ha...

May 12, 2021 | Wednesday | News
EU inks the third contract with BioNTech/Pfizer securing 1.8 billion doses

The European Commission has approved a contract for 1.8 billion doses of the BioNTech/Pfizer vaccine. The contract cove...

May 11, 2021 | Tuesday | News
US approves Pfizer-BioNTech COVID-19 Vaccine for adolescents

The U.S. Food and Drug Administration (FDA) has expanded the emergency use authorization (EUA) for the Pfizer-BioNTech C...

May 11, 2021 | Tuesday | News
Australia's CSIRO suggests nasal delivery of Oxford-AZ vaccine to improve efficacy

The Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australia’s national science agency, has...

May 11, 2021 | Tuesday | News
China focuses on next-generation intranasal COVID-19 vaccines

COVID-19 infections continue to rise with several countries facing second-and third-wave infections with the newly evolv...

May 10, 2021 | Monday | News
WHO lists China's Sinopharm COVID-19 vaccine for emergency use

The World Health Organisation (WHO) has listed the Sinopharm COVID-19 vaccine for emergency use, giving the green light ...

May 10, 2021 | Monday | News
Oxford’s malaria vaccine shows significant 75% efficacy in early trial

A malaria vaccine created by scientists at the University of Oxford’s Jenner Institute has been found to be 77% ef...

May 4, 2021 | Tuesday | News
WHO issues emergency use listing to Moderna COVID-19 vaccine

Moderna, Inc., a US based biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, has announced...

May 1, 2021 | Saturday | News